NCT06829121View on ClinicalTrials.gov

Ultrasound-based Morphometry for the Development of Diagnostic and Prognostic Markers in Current and Chronic Diseases

CompletedOBSERVATIONAL

Enrollment

900

Participants

Timeline

Start Date

October 1, 2020

Primary Completion Date

May 20, 2022

Study Completion Date

December 1, 2024

Conditions

UltrasoundSarcopeniaMuscle Loss

Interventions

DIAGNOSTIC_TEST

Ultrasound

The thickness of the psoas muscle and the musculus quadriceps femoris will be measured by ultrasound

Trial Locations (1)

55131

Universitatsmedizin Mainz, Mainz

All Listed Sponsors

lead

Universitatsmedizin Mainz - 1. Medizinische Klinik

OTHER

NCT06829121 - Ultrasound-based Morphometry for the Development of Diagnostic and Prognostic Markers in Current and Chronic Diseases | Biotech Hunter | Biotech Hunter